No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
566 |
4. Check minimum number of eventsNone |
566 |
5. Include endpointsNone |
566 |
6. Filter based on genotype QC (FinnGen only) |
566 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Anorexia
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6577 | 4584 | 1950 |
| Only index persons | 5178 | 3786 | 1392 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.13 | 0.05 |
| Only index persons | 0.12 | 0.14 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 21.18 | 18.99 | 25.35 |
| Only index persons | 19.50 | 18.42 | 22.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 566 | 450 | 116 |
| Unadjusted period prevalence (%) | 0.13 | 0.15 | 0.05 |
| Median age at first event (years) | 27.72 | 19.85 | 58.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 515
- Matched controls
- 5148
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R63.0
ICD-10 Finland
Anorexia
4834.6
312.6
269
*
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
137.9
126
*
78400
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Anorexia
+∞
99.2
92
*
F50.0
ICD-10 Finland
Anorexia nervosa
89.1
81.2
89
12
F50.9
ICD-10 Finland
Eating disorder, unspecified
30.4
46.4
62
23
F50.1
ICD-10 Finland
Atypical anorexia nervosa
56.4
43.5
51
10
7830A
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Anorexia
+∞
38.0
36
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.5
34.6
96
174
N06AB03
ATC
fluoxetine; oral
4.1
26.1
115
341
N05AH04
ATC
quetiapine; oral
3.5
25.7
142
508
N05AX08
ATC
risperidone; systemic
5.3
25.2
82
178
R53
ICD-10 Finland
Malaise and fatigue
3.1
23.8
160
654
E87.6
ICD-10 Finland
Hypokalaemia
10.0
23.3
47
51
N05AH03
ATC
olanzapine; systemic
5.7
22.9
69
137
N06AX11
ATC
mirtazapine; oral
2.7
22.4
208
1039
F50.2
ICD-10 Finland
Bulimia nervosa
19.5
22.0
33
18
R63.4
ICD-10 Finland
Abnormal weight loss
8.0
21.8
50
68
P86
ICPC
Anorexia nervosa/bulimia
34.1
20.4
26
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
19.4
192
976
N03AG01
ATC
valproic acid; systemic, rectal
5.2
19.0
61
130
N05BA04
ATC
oxazepam; oral
2.6
18.6
166
791
N03AX09
ATC
lamotrigine; oral
5.1
18.6
61
133
N05AA02
ATC
levomepromazine; systemic
6.3
18.4
50
87
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
17.0
93
321
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
16.8
109
425
R11
ICD-10 Finland
Nausea and vomiting
3.5
14.8
74
238
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.6
14.8
52
122
P99
ICPC
Psychological disorders other
7.7
14.7
34
47
N05CD07
ATC
temazepam; oral
3.2
14.7
82
287
N06AX16
ATC
venlafaxine; oral
2.8
14.6
107
448
D64.9
ICD-10 Finland
Anaemia, unspecified
3.6
14.3
67
205
N03AX16
ATC
pregabalin; oral
2.4
13.9
139
689
N06AX03
ATC
mianserin; oral
5.6
13.8
40
76
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.3
13.7
42
85
N06AB04
ATC
citalopram; systemic
2.4
13.7
137
676
30650
ICD-8 Finland
Special symptoms not elsewhere classified, Feeding disturbance
+∞
13.6
13
*
N91.1
ICD-10 Finland
Secondary amenorrhoea
6.7
13.4
34
54
E86
ICD-10 Finland
Volume depletion
8.9
13.4
28
33
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
13.2
161
875
N05BA01
ATC
diazepam; systemic, rectal
2.8
13.2
90
359
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.5
13.0
30
42
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.3
12.9
48
120
K59.09
ICD-10 Finland
Constipation, unspecified
4.4
12.8
47
116
P29
ICPC
Psychological sympt/compl other
3.8
12.7
54
152
N05AX12
ATC
aripiprazole; systemic
4.6
12.4
43
100
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.7
12.4
28
38
N05AH02
ATC
clozapine; systemic
7.5
12.2
28
39
N05CF01
ATC
zopiclone; oral
2.1
11.9
174
1013
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
11.9
50
140
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.5
11.8
42
100
K59.0
ICD-10 Finland
Constipation
4.1
11.5
45
118
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.9
11.5
73
277
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
11.4
122
618
A03FA02
ATC
cisapride; oral, rectal
3.5
11.3
53
162
N05AN01
ATC
lithium; oral
6.3
11.2
29
48
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
11.1
57
187
N06AB05
ATC
paroxetine; oral
3.5
11.1
52
159
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.5
11.1
52
159
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.2
10.8
41
105
AA400
NOMESCO Finland
Electroconvulsive therapy
13.3
10.7
18
14
N05BA06
ATC
lorazepam; systemic, sublingual
4.0
10.7
42
111
N05AF03
ATC
chlorprothixene; systemic
5.8
10.6
29
52
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
17.1
9.9
15
9
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
9.8
121
650
N03AE01
ATC
clonazepam; systemic
3.5
9.8
45
136
P01
ICPC
Feeling anxious/nervous/tense
2.5
9.8
82
365
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
13.7
9.7
16
12
N06AB10
ATC
escitalopram; oral
2.1
9.7
129
716
F50.8
ICD-10 Finland
Other eating disorders
11.7
9.6
17
15
A06AD11
ATC
lactulose; oral
2.5
9.6
78
341
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
8.9
9.4
19
22
A28
ICPC
Limited function/disability NOS
2.5
9.4
77
340
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.6
9.3
31
70
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.9
9.2
22
33
P74
ICPC
Anxiety disorder/anxiety state
4.1
9.2
35
90
SPAT1240
SPAT
Therapeutic discussion
2.4
9.0
77
347
N05AB03
ATC
perphenazine; systemic, rectal
4.3
8.8
32
79
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
50.9
8.7
10
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.9
8.5
27
58
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
8.5
79
368
X78
ICD-10 Finland
Intentional self-harm by sharp object
91.5
8.4
9
*
N06AB06
ATC
sertraline; oral
2.4
8.4
71
318
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.3
8.3
19
27
SPAT1301
SPAT
No procedures
1.9
8.3
161
1015
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.1
8.3
31
79
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.9
8.2
32
85
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.0
8.2
25
52
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
2.8
8.1
51
193
F60.0
ICD-10 Finland
Paranoid personality disorder
33.9
8.1
10
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
22.4
8.0
11
5
N04AA02
ATC
biperiden; systemic
6.3
7.9
20
33
A04
ICPC
Weakness/tiredness general
2.2
7.9
82
406
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
7.8
41
138
N06AA12
ATC
doxepin; systemic
3.6
7.7
33
95
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
45.7
7.7
9
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
7.7
67
304
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
7.6
71
335
M05BA04
ATC
alendronic acid; oral
2.9
7.6
44
159
R33
ICD-10 Finland
Retention of urine
3.4
7.5
35
108
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
7.5
36
114
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
7.5
71
338
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
81.2
7.4
8
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
13.6
7.4
12
9
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.0
7.4
28
73
3075B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]
+∞
7.3
7
*
7830C
ICD-9 Finland
NA
+∞
7.3
7
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
16.0
7.3
11
7
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
7.2
50
201
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
7.2
34
107
62600
ICD-8 Finland
Disorders of menstruation, Absent
20.3
7.2
10
5
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.4
7.1
20
38
C07AA05
ATC
propranolol; systemic
1.9
7.1
112
656
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.6
7.0
23
52
N06AX21
ATC
duloxetine; oral
2.3
7.0
63
291
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.0
184
1269
N02AA05
ATC
oxycodone; systemic
2.3
6.9
65
308
N03AF02
ATC
oxcarbazepine; oral
4.1
6.9
25
63
R55
ICD-10 Finland
Syncope and collapse
2.5
6.8
53
225
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
6.8
39
140
UJD02
NOMESCO Finland
Gastroscopy
3.4
6.7
30
91
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.6
116
702
F21
ICD-10 Finland
Schizotypal disorder
12.5
6.6
11
9
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
12.5
6.6
11
9
N05AA01
ATC
chlorpromazine; systemic, rectal
8.9
6.6
13
15
F50.3
ICD-10 Finland
Atypical bulimia nervosa
7.0
6.6
15
22
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
6.5
31
98
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.3
6.5
16
26
R50.9
ICD-10 Finland
Fever, unspecified
2.1
6.5
73
375
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
7.5
6.4
14
19
N06AX26
ATC
vortioxetine; oral
2.9
6.4
37
133
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.4
190
1345
N06AA04
ATC
clomipramine; systemic
6.1
6.3
16
27
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.3
100
585
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
27.0
6.2
8
*
F50
ICD-10 Finland
Eating disorders
27.0
6.2
8
*
G03DB01
ATC
dydrogesterone; oral
1.9
6.2
88
496
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.1
6.2
22
55
P76
ICPC
Depressive disorder
2.6
6.1
43
174
188
Kela drug reimbursment
Psychosis requiring demanding treatment
8.7
6.1
12
14
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
6.1
46
195
F32.8
ICD-10 Finland
Other depressive episodes
5.3
6.1
17
33
N05BA12
ATC
alprazolam; oral
2.3
6.1
56
261
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
10.2
6.1
11
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
6.0
46
196
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
144
480
3.68
36.44
8.3
5.9
mmol/l
1.1
1.1
0.00
135
448
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
217
1079
2.64
26.06
2.6
2.2
mg/l
2.7
3.0
0.93
193
913
(3024561) Albumin [Mass/volume] in Serum or Plasma
287
1660
2.48
24.66
7.0
4.4
g/l
35.3
36.3
1.98
270
1542
(3036481) Cortisol [Moles/volume] in Serum or Plasma
117
442
3.08
23.39
2.3
2.0
nmol/l
378.2
377.1
0.02
111
406
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
267
1544
2.38
22.33
2.2
1.9
pmol/l
96.4
97.1
0.07
156
800
(3015377) Calcium [Moles/volume] in Serum or Plasma
249
1408
2.37
21.79
4.2
3.0
mmol/l
2.3
2.4
0.27
222
1254
(3012095) Magnesium [Moles/volume] in Serum or Plasma
142
623
2.71
21.36
5.4
3.4
mmol/l
0.8
0.8
0.11
135
583
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
311
1980
2.27
20.04
10.1
6.3
mmol/l
1.2
1.2
0.37
278
1658
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
282
1779
2.17
17.94
9.3
6.1
mmol/l
1.2
1.2
0.70
265
1619
(3021960) Folate [Moles/volume] in Serum or Plasma
175
917
2.31
17.56
1.8
1.5
nmol/l
21.2
20.7
0.13
154
783
(3026008) Bacteria identified in Urine by Culture
224
1310
2.17
17.09
3.8
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
353
2.88
17.06
3.2
2.7
g/l
0.2
0.2
0.28
78
331
(3027945) Reticulocytes/100 erythrocytes in Blood
99
404
2.76
16.86
3.7
3.0
%
1.6
1.8
0.68
91
358
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
222
1306
2.15
16.58
3.8
2.4
u/l
59.9
56.2
0.62
207
1204
(3023368) Bacteria identified in Blood by Culture
177
959
2.23
16.20
6.0
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
137
675
2.36
15.64
2.1
1.6
nmol/l
1170.0
1173.3
0.02
123
502
(3018418) pH of Serum or Plasma
204
1183
2.13
15.62
5.8
3.7
ph
7.4
7.4
0.05
29
230
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
316
2156
2.05
15.54
7.5
5.6
umol/l
9.5
10.7
1.95
302
2033
(3022948) Iron [Moles/volume] in Serum or Plasma
127
607
2.41
15.52
2.6
2.2
umol/l
13.2
13.5
0.18
116
557
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
200
1155
2.13
15.45
2.7
2.0
u/l
156.6
157.5
0.01
189
1096
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
120
560
2.45
15.45
2.5
1.6
%
1.6
1.4
1.95
105
505
(42870588) Differential panel, method unspecified - Blood
235
1449
2.06
15.19
9.1
5.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
117
546
2.44
15.03
2.6
2.2
g/l
2.3
2.4
1.29
105
501
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
140
714
2.28
14.65
3.4
2.5
mmol/l
2.4
2.4
0.02
118
627
(3001604) Monocytes [#/volume] in Blood
324
2267
2.00
14.44
9.8
5.4
e9/l
0.6
0.5
0.32
287
1978
(3006315) Basophils [#/volume] in Blood
325
2280
2.00
14.33
9.8
5.5
e9/l
0.0
0.0
0.73
290
1986
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
264
2.93
14.29
2.0
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
360
2624
2.02
14.16
16.3
8.3
e9/l
3.8
4.0
0.74
323
2288
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
122
595
2.34
14.13
1.9
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
331
2365
1.96
13.53
10.6
5.7
e9/l
0.2
0.2
0.51
300
2090
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
279
1887
1.94
13.37
3.0
2.3
nmol/l
80.9
75.8
1.84
255
1712
(3019198) Lymphocytes [#/volume] in Blood
328
2346
1.95
13.25
9.9
5.4
e9/l
1.8
2.0
2.81
299
2085
(3001122) Ferritin [Mass/volume] in Serum or Plasma
323
2306
1.93
13.04
3.9
2.8
ug/l
103.3
79.9
1.48
311
2145
(3031040) Bacteria [#/volume] in Urine by Automated count
392
3012
1.98
12.43
6.5
4.2
e6/l
1076.7
2944.3
—
6
43
(3022096) Basophils/100 leukocytes in Blood
294
2056
1.89
12.42
9.7
5.5
%
0.6
0.7
0.78
278
1908
(40768797) Stomach Pathology biopsy report
114
574
2.23
12.11
1.3
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
225
1458
1.90
11.90
4.3
3.0
u/l
25.8
29.6
2.73
214
1394
(3000991) Gas panel - Venous blood
72
298
2.62
11.78
7.1
9.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
300
2138
1.86
11.69
9.5
5.4
%
2.6
2.7
0.33
285
1983
(3019069) Monocytes/100 leukocytes in Blood
301
2149
1.86
11.65
9.9
5.7
%
8.6
8.2
1.27
287
2008
(3023520) Reticulocytes [#/volume] in Blood
69
282
2.65
11.57
2.9
2.7
e9/l
67.8
71.6
0.38
51
210
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
101
493
2.28
11.52
2.8
2.4
%
22.3
22.5
0.07
90
420
(3002032) Base excess in Venous blood by calculation
75
325
2.51
11.15
7.3
5.3
mmol/l
2.3
1.8
0.33
59
247
(3013826) Glucose [Moles/volume] in Serum or Plasma
329
2443
1.83
10.94
6.2
4.6
mmol/l
6.4
6.4
0.05
304
2223
(3013707) Erythrocyte sedimentation rate by Westergren method
416
3328
1.94
10.88
5.2
3.8
mm/h
12.1
10.3
1.69
390
3084
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
87
408
2.34
10.87
1.8
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
303
2214
1.79
10.44
9.7
5.5
%
27.9
29.1
1.03
288
2062
(3003396) Base excess in Arterial blood by calculation
79
362
2.37
10.39
5.2
8.6
mmol/l
1.4
1.1
0.23
69
290
(3028707) Methadone [Presence] in Urine by Screen method
36
108
3.49
10.30
3.7
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
300
2192
1.78
10.28
9.5
5.3
%
57.5
56.7
0.53
284
2045
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
412
3313
1.90
10.25
10.5
6.6
u/l
76.8
76.6
0.02
392
3099
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
83
403
2.24
9.52
1.8
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
187
1216
1.80
9.30
1.4
1.3
u/ml
0.6
1.8
2.13
60
323
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
215
1464
1.76
9.10
4.7
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
390
3136
1.78
9.07
5.6
4.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
27
73
3.83
8.99
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
48
188
2.70
8.74
4.1
6.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
281
2.35
8.33
2.2
2.4
ug/l
2.7
5.1
2.46
57
241
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
211
1458
1.71
8.31
4.0
3.3
ng/l
27.3
36.1
0.74
135
831
(3032080) INR in Blood by Coagulation assay
209
1448
1.70
8.11
6.8
7.2
inr
1.1
1.1
0.49
62
450
(3011288) Drugs identified in Urine by Screen method
44
175
2.64
7.78
4.2
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
201
2.52
7.65
1.6
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
29
5.29
7.48
1.5
1.2
e6/l
8340.3
1520.7
—
10
19
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
45
185
2.56
7.45
10.4
6.5
mmol/l
24.1
23.9
0.16
39
173
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
132
823
1.79
7.34
2.1
1.6
pmol/l
439.0
28571861.2
1.05
119
707
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
244
2.34
7.31
1.6
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
99
565
1.91
7.29
2.0
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
62
298
2.21
7.26
3.6
3.9
ng/l
80.1
76.7
0.10
55
264
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
377
3092
1.66
7.24
4.5
3.0
u/l
36.0
37.4
0.22
359
2916
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
434
3701
1.74
7.12
5.8
4.1
pmol/l
14.5
14.5
0.03
410
3413
(3009261) Glucose [Presence] in Urine by Test strip
295
2289
1.60
7.01
4.9
3.4
estimate
0.0
0.0
0.50
51
422
(3011397) Hemoglobin [Presence] in Urine by Test strip
153
1014
1.70
6.80
4.6
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
62
309
2.13
6.64
4.3
3.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
78
426
1.96
6.52
16.1
18.1
inr
1.2
1.2
0.10
12
66
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
29
4.92
6.48
1.4
1.2
e6/l
33285.0
46777.3
—
8
15
(3019150) Specific gravity of Urine by Refractometry
150
1001
1.68
6.46
5.0
3.5
kg/l
1.0
1.0
0.04
23
144
(3035350) Ketones [Presence] in Urine by Test strip
289
2264
1.56
6.37
4.9
3.3
estimate
0.0
0.0
0.00
53
429
(3007164) IgA [Mass/volume] in Serum or Plasma
158
1074
1.65
6.32
1.8
1.4
g/l
2.0
2.2
0.71
93
654
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
98
2.95
6.29
1.6
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
289
2269
1.56
6.27
6.2
4.6
estimate
0.0
0.0
0.50
51
438
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
29
104
2.89
6.25
2.0
2.2
ug/l
221.8
245.4
0.10
29
92
(3004588) Protein electrophoresis panel - Serum or Plasma
48
221
2.28
6.23
3.1
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
132
861
1.70
6.16
4.2
2.4
e6/l
7.7
7.9
0.04
119
753
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
249
2.20
6.15
6.6
4.3
mmol/l
2.3
1.6
0.55
37
179
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
142
2.56
5.98
1.4
2.2
g/l
1.4
1.4
0.04
30
119
(3009214) Lutropin [Units/volume] in Serum or Plasma
40
176
2.37
5.77
1.6
1.5
u/l
8.6
10.3
0.37
32
141
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
28
4.73
5.76
1.8
1.6
promille
1.0
1.3
—
8
21
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
152
1048
1.62
5.67
2.6
2.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
17
5.97
5.64
5.8
6.5
umol/l
116.8
176.3
—
5
7
(1761868) Lipid panel - Serum or Plasma
116
1699
0.60
5.59
2.8
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
661
1.72
5.54
3.4
2.5
e6/l
1.3
1.0
0.65
63
353
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
94
2.85
5.54
1.8
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
206
1534
1.54
5.48
5.5
3.4
e6/l
76.6
67.1
0.14
148
1019
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
38
4.03
5.47
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
130
2.55
5.47
1.3
1.4
ug/g
302.0
320.2
0.22
22
68
(3009343) pH of Capillary blood
52
262
2.08
5.42
6.7
4.2
ph
7.4
7.4
—
10
24
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
72
409
1.87
5.34
2.7
2.4
u/l
46.8
31.4
0.65
62
343
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
18
5.64
5.34
1.4
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
160
1131
1.58
5.34
4.8
2.8
e6/l
0.5
0.4
0.08
123
831
(40758558) Short blood count panel - Blood
162
1150
1.57
5.30
10.7
6.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
22
5.08
5.28
1.6
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
159
1128
1.57
5.20
4.7
2.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
102
648
1.70
5.19
2.9
2.4
ug/g
166.2
97.9
0.64
83
501
(3002582) Erythrocytes [#/volume] in Urine
171
1247
1.53
4.91
5.1
2.9
e6/l
39.6
112.1
0.72
138
935
(21494434) Karyotype in Bone marrow
12
28
4.36
4.84
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
38
178
2.22
4.77
1.6
1.8
nmol/l
7.3
10.7
1.26
30
161
(3007853) Bacteria identified in Skin by Aerobe culture
80
487
1.75
4.74
2.2
1.6
—
—
—
0
0
(3020891) Body temperature
30
128
2.42
4.66
4.6
4.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
141
2.35
4.63
2.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
39
3.66
4.51
4.6
4.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
40
197
2.11
4.45
3.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
118
814
1.57
4.29
3.7
2.5
mosm/kgh2o
528.4
550.1
0.42
99
692
(46235355) HIV 1 and 2 tests - Meaningful Use set
162
1202
1.49
4.19
2.1
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
184
1401
1.46
4.18
2.8
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
57
3.04
4.15
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
44
231
1.98
4.14
3.4
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
152
1117
1.49
4.12
6.8
4.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
156
2.18
4.08
2.1
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
95
631
1.61
4.04
3.6
2.7
e6/l
4.5
3.4
0.42
53
326
(3021440) Promyelocytes/100 leukocytes in Blood
56
322
1.82
4.02
3.7
4.3
%
0.2
0.2
0.07
20
86
(3024928) Oxygen saturation in Venous blood
19
70
2.77
3.96
9.7
7.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
70
2.77
3.96
2.1
4.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
492
4539
1.64
3.88
25.0
12.5
mmol/l
139.0
139.6
4.77
487
4406
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
101
2.44
3.86
1.3
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
474
4336
1.57
3.86
6.8
4.8
mu/l
1.8
2.1
0.60
449
4024
(3000494) Fungus identified in Specimen by Culture
77
491
1.66
3.85
1.7
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
46
252
1.90
3.84
3.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
46
252
1.90
3.84
3.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
102
699
1.56
3.80
4.1
3.2
ng/l
341.2
222.1
0.24
71
459
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
39
3.39
3.78
1.4
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
46
254
1.88
3.76
3.3
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
33
162
2.10
3.73
6.8
4.5
%
0.7
0.7
0.59
33
157
(3022806) Fractional oxyhemoglobin in Capillary blood
14
45
3.16
3.67
2.7
1.6
%
91.5
90.6
0.24
14
45
(3035880) pH of Pleural fluid
9
16
5.70
3.67
1.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
53
309
1.79
3.65
3.6
4.1
%
0.5
0.8
0.36
17
68
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
40
3.30
3.64
1.4
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
57
341
1.75
3.60
3.7
4.2
%
0.8
1.1
0.35
20
98
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
45
251
1.86
3.57
12.7
7.7
mmol/l
25.5
24.8
0.54
45
251
(3023103) Potassium [Moles/volume] in Serum or Plasma
492
4561
1.60
3.54
25.3
12.6
mmol/l
3.9
3.9
1.44
486
4416
(3021901) Oxygen saturation in Capillary blood
17
63
2.75
3.52
8.8
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
132
2.18
3.51
4.0
2.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
13
6.22
3.51
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
69
2.66
3.50
5.0
2.1
%
16.5
16.2
—
10
32
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
129
946
1.47
3.48
2.7
3.1
ng/l
1998.3
1075.7
1.37
109
774
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
513
4809
1.71
3.48
14.3
9.0
u/l
22.5
24.4
2.33
501
4647
(3009508) Creatinine [Moles/volume] in Urine
152
1152
1.44
3.45
4.2
2.9
mmol/l
6.9
7.5
0.91
137
979
(3029937) Albumin [Presence] in Urine by Test strip
158
1207
1.43
3.43
6.3
3.6
estimate
0.0
0.0
0.50
53
430
(1616796) Gas panel - Central venous blood
18
70
2.62
3.41
6.9
2.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
42
3.14
3.39
2.3
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
53
2.88
3.38
2.7
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
115
2.23
3.33
3.1
3.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
109
2.26
3.30
3.3
8.0
%
1.4
1.7
0.84
24
101
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
255
2125
1.36
3.27
4.6
3.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
33
3.38
3.20
1.5
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
61
2.67
3.16
2.1
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
159
2.00
3.16
5.5
12.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
20
4.55
3.12
1.2
1.2
u/l
12.4
14.5
—
9
20
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
485
1.58
3.11
3.5
2.8
umol/l
3.7
5.6
4.73
62
417
(3037522) Nuclear Ab [Titer] in Serum
92
646
1.51
3.06
1.4
1.4
titre
227.4
539.1
4.61
19
138
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
16
5.05
3.06
1.5
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
34
183
1.91
3.03
2.1
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
45
265
1.76
3.03
1.4
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
12
5.89
3.03
1.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
94
2.28
3.00
4.3
3.9
%
59.7
57.4
0.31
21
94
(3048879) Bone marrow aspiration report
5
5
10.07
2.98
1.6
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
192
1.88
2.95
2.3
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
35
3.19
2.94
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
592
0.56
2.79
2.5
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
311
1.67
2.78
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
42
249
1.74
2.78
2.6
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
18
78
2.35
2.77
7.1
2.3
kpa
9.1
8.7
0.30
18
78
(3013290) Carbon dioxide [Partial pressure] in Blood
18
78
2.35
2.77
7.1
2.3
kpa
5.0
4.9
0.41
18
78
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
10
6.05
2.70
1.8
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
92
2.22
2.70
3.9
3.6
e9/l
4.3
4.2
0.10
20
92
(36660697) Celiac disease serology panel - Serum
63
419
1.57
2.69
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
169
1.88
2.68
1.5
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
52
331
1.63
2.66
2.4
2.1
u/l
23941.9
1808.5
0.91
13
140
(40768806) Pleura Pathology biopsy report
10
32
3.16
2.65
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
55
2.58
2.63
3.3
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
38
2.93
2.59
1.7
1.1
u/ml
2.4
0.1
—
5
10
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
390
1.57
2.59
4.4
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
213
1779
1.32
2.52
5.4
3.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
26
3.50
2.49
3.3
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
14
57
2.49
2.46
4.5
12.9
mmol/l
10.6
10.8
0.11
14
51
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
314
1.61
2.45
2.5
2.4
ml/min/173m2
66.7
74.7
0.71
24
123
(3035637) Corticotropin [Mass/volume] in Plasma
15
64
2.38
2.40
2.1
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
77
2.25
2.39
1.3
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
14
58
2.45
2.38
4.5
12.7
mmol/l
105.2
105.8
0.19
14
52
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
489
4610
1.45
2.37
23.3
11.5
mg/l
23.8
20.7
1.35
377
3538
(3022313) Gas panel - Capillary blood
34
200
1.74
2.34
6.7
4.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
48
310
1.60
2.33
4.0
4.3
%
0.0
0.2
0.86
17
73
(3019225) pH of Specimen
55
368
1.55
2.31
7.7
3.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
92
2.10
2.29
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
72
2.26
2.29
1.2
1.1
—
—
—
0
0
(4198724)
8
23
3.51
2.27
1.6
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
265
1.63
2.25
2.3
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
125
981
1.35
2.24
4.2
2.6
umol/l
293.8
6942.2
4.80
105
864
(21494890) Protein electrophoresis panel - 24 hour Urine
9
29
3.14
2.23
1.4
2.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
536
5166
1.71
2.19
33.3
17.1
e9/l
260.8
260.0
0.10
527
5050
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
24
130
1.88
2.15
2.0
1.7
—
234.3
—
0
7
(3003181) Sodium [Moles/volume] in Urine
13
55
2.40
2.13
1.6
1.4
mmol/l
88.0
65.8
—
8
47
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
106
817
1.37
2.13
2.4
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
108
835
1.36
2.13
1.3
1.3
iu/ml
14.1
28.3
2.95
28
266
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
95
2.03
2.13
2.3
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
536
5170
1.69
2.12
33.3
17.1
e12/l
4.3
4.5
16.61
527
5043
(3016018) Differential panel - Cerebral spinal fluid
11
43
2.59
2.10
3.8
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
25
139
1.84
2.08
1.5
1.6
iu/ml
0.0
0.0
—
8
22
(3010813) Leukocytes [#/volume] in Blood
536
5173
1.68
2.08
33.3
17.1
e9/l
6.5
6.7
1.95
527
5040
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
20
3.53
2.06
1.7
2.9
u/ml
1520.3
603.5
—
7
20
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
124
985
1.33
2.05
1.8
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
44
289
1.57
2.02
1.2
1.1
—
77.3
—
0
7
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
604
1.40
1.99
1.8
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
346
0.53
1.99
1.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
33
2.75
1.94
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
34
2.67
1.87
2.1
2.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
17
3.56
1.84
2.2
2.8
ug/l
52.4
96.1
—
6
17
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
108
1.88
1.84
1.4
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
138
1.77
1.82
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
94
1.94
1.82
2.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
482
0.62
1.82
1.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
35
2.60
1.80
1.1
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
146
1.75
1.80
4.1
2.9
g/l
0.3
0.3
0.05
12
56
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
23
3.07
1.80
1.7
1.5
umol/l
27.0
30.0
—
7
23
(3022621) pH of Urine by Test strip
43
290
1.52
1.78
2.8
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
38
561
0.65
1.77
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
41
2.46
1.76
1.1
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
291
1.52
1.76
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
18
3.36
1.75
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
18
3.36
1.75
1.3
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
55
393
1.44
1.73
1.5
1.4
iu/l
20.7
24.8
0.51
50
336
(3021589) Normoblasts [#/volume] in Blood
234
2055
1.24
1.70
15.0
8.4
e9/l
0.0
0.0
0.75
197
1682
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
382
3536
1.25
1.68
3.7
3.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
1.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
1.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
1.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
69
2.06
1.66
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
318
2893
1.23
1.62
4.2
3.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
125
1026
1.28
1.62
2.3
1.8
mg/l
1.3
1.1
0.36
88
758
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
84
1.93
1.61
2.6
1.7
—
—
—
0
0
(3036489) Thrombin time
29
183
1.62
1.60
4.5
2.5
s
20.3
21.1
0.62
24
162
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
70
2.03
1.60
2.7
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
442
4174
1.27
1.56
18.0
10.2
ml/min/173m2
87.2
87.1
0.02
366
3343
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
78
1.95
1.55
1.7
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
78
1.95
1.55
1.7
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
64
2.06
1.55
2.1
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
111
903
1.29
1.54
2.5
2.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
27
2.61
1.52
1.1
1.1
iu/ml
207.9
140.6
—
7
27
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
27
2.61
1.52
6.9
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
505
4859
1.36
1.50
19.2
10.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
416
3912
1.24
1.46
5.2
4.8
mmol/mol
38.3
38.6
0.20
387
3678
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
80
1.90
1.46
6.7
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
95
764
1.29
1.44
1.7
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
66
1.99
1.44
2.1
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
16
3.14
1.44
1.8
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
22
2.75
1.44
1.2
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
149
1.64
1.43
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
11
212
0.51
1.43
1.0
1.1
—
—
—
0
0
(4062490)
9
40
2.27
1.40
1.6
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
46
2.20
1.40
3.4
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
367
1.40
1.39
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
446
4236
1.25
1.37
4.6
3.9
mmol/l
5.7
5.8
0.02
417
3898
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
151
1.62
1.37
1.4
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
17
2.96
1.36
2.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
3.2
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
105
1.74
1.34
2.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
454
4328
1.25
1.30
23.1
12.6
%
38.4
39.6
3.80
327
3414
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
3.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
99
814
1.26
1.27
1.4
1.3
u/ml
3.3
9.2
2.06
33
332
(44790048)
9
44
2.06
1.27
2.7
1.5
—
—
—
0
0
(44806118)
9
44
2.06
1.27
2.7
1.5
—
—
—
0
0
(44790049)
9
44
2.06
1.27
2.7
1.5
—
—
—
0
0
(44790047)
9
44
2.06
1.27
2.7
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
155
1.57
1.25
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
25
2.41
1.24
1.3
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
116
1.66
1.23
4.1
1.6
mg/l
498.2
411.2
0.41
19
109
(3023410) Appearance of Cerebral spinal fluid
11
56
1.98
1.22
6.4
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
49
2.06
1.22
1.7
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
37
2.18
1.22
2.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
141
1.58
1.19
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
29
199
1.48
1.17
1.7
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
241
1.44
1.17
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
327
1.37
1.16
7.5
3.7
mmol/l
1.2
1.2
1.53
37
283
(3035320) C reactive protein [Mass/volume] in Body fluid
0
33
0.00
1.16
0.0
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
45
336
1.37
1.16
4.8
2.5
g/l
9.1
10.0
0.69
39
307
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
39
2.07
1.15
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
70
559
1.29
1.15
2.1
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
29
200
1.47
1.14
4.1
2.8
e6/l
0.3
0.2
0.35
29
194
(40768443) Skin Pathology biopsy report
25
167
1.52
1.14
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
103
1.67
1.14
2.6
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
436
4158
1.21
1.13
3.6
3.4
mmol/l
1.2
1.2
1.34
410
3863
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
88
1.72
1.12
1.9
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
160
1.52
1.11
1.3
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
3.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
32
2.20
1.08
1.6
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
138
1.54
1.04
1.4
1.9
iu/l
1.9
6.0
—
8
45
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
47
1.93
1.02
2.3
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
300
1.36
1.02
4.0
2.1
e9/l
4.7
3.9
0.35
31
248
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
37
1.90
0.94
2.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
59
478
1.26
0.89
10.5
6.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
111
1.55
0.88
4.6
1.5
e6/l
1.5
3.9
1.47
17
89
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
111
1.55
0.88
4.6
1.6
e6/l
76.5
135.9
0.28
17
92
(3019230) Fractional oxyhemoglobin in Venous blood
10
56
1.80
0.88
16.3
8.0
%
52.7
62.1
—
10
56
(3044290) Cell count panel - Cerebral spinal fluid
15
95
1.59
0.88
4.9
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
120
1.52
0.86
1.6
1.4
nmol/l
0.4
0.4
0.02
11
99
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.84
2.7
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
31
1.95
0.84
1.0
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
46
1.75
0.83
1.1
1.4
pmol/l
549.8
392.7
—
8
38
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.82
1.0
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
339
1.29
0.81
3.7
3.9
ug/l
31.0
21.9
0.19
33
271
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
20
139
1.45
0.80
1.1
1.2
—
25.6
—
0
7
(4034850)
20
140
1.44
0.78
14.0
7.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
58
478
1.24
0.77
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
34
434
0.77
0.75
1.6
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
19
133
1.44
0.74
1.1
1.2
—
3.0
—
0
16
(3049717) Cytology report of Urine Cyto stain
6
107
0.56
0.73
3.2
2.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
19
134
1.43
0.72
1.1
1.2
—
17.6
—
0
27
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
101
1.50
0.70
1.1
1.2
—
1.2
—
0
6
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
11.0
8.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
48
395
1.24
0.67
7.1
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
202
1871
1.12
0.65
2.0
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
49
406
1.23
0.64
1.3
1.2
iu/ml
57.8
164.2
3.24
14
166
(4035726)
43
352
1.24
0.63
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
147
1.37
0.62
1.5
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
63
1.60
0.62
1.6
1.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.2
1.4
mmol/l
2.6
1.8
—
5
30
(3044941) Cell count panel - Synovial fluid
8
51
1.58
0.60
1.3
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
447
4344
1.14
0.60
4.1
3.8
mmol/l
4.7
4.8
0.92
422
4075
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
57
666
0.84
0.59
1.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
89
1.47
0.58
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
35
1.72
0.58
1.5
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
54
1.49
0.57
1.3
1.1
—
—
—
0
0
(3013512) EKG study
118
1067
1.13
0.56
4.0
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
73
1.52
0.56
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
90
1.45
0.56
3.0
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
452
4404
1.13
0.55
4.3
4.2
mmol/l
2.7
2.8
2.27
426
4105
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
38
1.58
0.54
1.8
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
414
4015
1.12
0.54
27.2
14.0
%
13.7
13.5
0.62
408
3950
(3051611) Lipemic interference index of Serum or Plasma
6
39
1.54
0.53
5.3
3.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
83
1.46
0.52
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
92
1.42
0.51
1.0
1.0
u/ml
1.6
1.7
—
6
45
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
1105
1.12
0.50
1.8
1.6
mmol/l
1.3
1.3
0.14
103
956
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
101
1.40
0.50
1.1
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(4010399)
34
281
1.22
0.48
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
2.9
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
443
4323
1.11
0.47
4.0
3.8
mmol/l
1.6
1.5
2.03
416
4038
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
191
1.27
0.47
1.9
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
85
1.42
0.47
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
183
1.27
0.45
1.6
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
107
979
1.11
0.44
4.0
3.1
mg/l
47.7
410.9
1.67
83
615
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
31
1.62
0.43
3.2
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
31
1.62
0.43
5.8
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
112
1029
1.11
0.43
4.7
3.9
mg/mmol
15.0
10.0
0.37
83
631
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
2.6
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
32
1.57
0.42
8.8
2.3
e9/l
0.2
0.2
—
5
23
(40768441) Liver Pathology biopsy report
5
33
1.52
0.41
1.0
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
33
1.52
0.41
2.2
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
60
1.34
0.40
1.4
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.9
—
1.3
—
0
18
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
35
1.43
0.39
8.8
2.1
e6/l
735.6
510.3
—
5
24
(3003694) ABO and Rh group [Type] in Blood
152
1425
1.09
0.39
1.5
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
67
1.35
0.38
2.0
2.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.6
2.6
nmol/l
3.3
147.2
—
5
37
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
433
1.14
0.36
2.1
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
301
1.17
0.36
1.1
1.2
—
27.5
—
0
16
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
73
1.38
0.34
1.1
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
127
1190
1.09
0.33
1.9
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
55
1.28
0.30
1.3
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
112
1.26
0.28
1.2
1.1
u/ml
7.8
6.6
—
7
53
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
103
1.27
0.28
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
139
1319
1.07
0.27
4.9
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
149
0.80
0.26
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
59
542
1.10
0.25
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
161
1.19
0.24
1.4
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
126
0.79
0.24
2.8
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
38
1.32
0.23
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
95
0.73
0.22
1.9
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
95
0.73
0.22
1.9
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
103
0.77
0.21
1.6
1.8
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
221
1.14
0.20
1.4
1.8
mg/l
3.1
2.7
0.12
17
152
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
52
1.16
0.19
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
53
1.13
0.18
1.8
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
91
1.21
0.17
2.7
2.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
1.1
1.3
nmol/l
0.6
0.5
—
7
55
(3050129) First trimester maternal screen panel - Serum or Plasma
35
320
1.10
0.17
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
309
0.90
0.17
2.3
2.8
ug/l
0.5
0.8
1.91
23
192
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
205
1.13
0.17
2.6
2.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
70
1.14
0.16
2.0
1.1
—
6619.3
—
0
19
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
56
527
1.07
0.15
5.0
4.9
ug/l
2.6
2.5
0.05
48
461
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
29
317
0.91
0.15
2.4
2.4
u/ml
49.9
37.6
0.20
29
301
(4306422)
9
82
1.10
0.15
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
50
470
1.07
0.14
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
108
1120
0.96
0.14
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
99
0.81
0.13
2.4
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
33
356
0.92
0.13
1.6
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
219
0.91
0.11
1.2
1.3
miu/ml
120.3
261.0
—
8
115
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
105
1.15
0.11
1.2
1.1
u/ml
0.2
0.7
—
5
45
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
11
96
1.15
0.10
1.2
1.1
—
12.5
—
0
9
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
125
1.12
0.10
1.5
1.1
u/ml
0.5
2.7
—
7
47
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
135
1.11
0.09
7.3
3.2
g/l
3.9
3.4
0.67
15
130
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
116
1.12
0.09
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
54
1.11
0.09
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
54
1.11
0.09
1.8
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
u/l
19.6
13.4
—
6
44
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
1.8
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
55
1.09
0.09
1.2
1.3
nmol/l
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
58
1.03
0.08
1.2
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.0
—
0.1
—
0
15
(3045424) Erythrocytes [Presence] in Urine
8
74
1.08
0.07
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
40
416
0.96
0.06
3.8
4.1
%
19.3
21.5
0.63
22
192
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
109
1.10
0.06
2.4
1.2
ug/l
19.6
2.9
0.82
12
94
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
228
1.05
0.05
1.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
49
476
1.03
0.04
3.7
3.8
%
35.9
32.3
1.16
38
318
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
219
1.05
0.04
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
321
0.96
0.03
1.5
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
26
270
0.96
0.03
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
26
270
0.96
0.03
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
26
270
0.96
0.03
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
26
269
0.96
0.02
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
133
1.05
0.01
1.6
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
22
213
1.03
0.01
1.5
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
217
0.97
0.01
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
22
214
1.03
0.00
1.6
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
285
0.98
0.00
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
186
1.02
0.00
2.2
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
233
0.99
0.00
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
34
337
1.01
0.00
2.2
2.3
—
19.0
—
0
22
(3000330) Specific gravity of Urine by Test strip
19
189
1.01
0.00
2.9
3.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
57
0.88
0.00
1.4
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.0
—
3.4
—
0
8
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
51
0.98
0.00
2.0
2.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
60.3
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
2.1
u/ml
7.1
81.5
—
5
48
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.0
—
0.7
—
0
6
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.5
—
73.8
—
0
6
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.3
—
0
5
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
178.0
—
0
5
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
70
1.00
0.00
1.1
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
1.2
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint R18_ANOREXIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| R18_ANOREXIA | 2.716 [2.11, 3.49] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.099 |
During the follow-up period (1.1.1998 — 31.12.2019), 508 out of 2219 females with R18_ANOREXIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| R18_ANOREXIA | 3.85 [2.44, 6.09] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 358 out of 1088 males with R18_ANOREXIA died.
Mortality risk
Mortality risk for people of age
years, who have R18_ANOREXIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.251% | 0.774% |
| 5 | 1.631% | 4.47% |
| 10 | 3.628% | 10.666% |
| 15 | 6.819% | 19.76% |
| 20 | 11.606% | 31.491% |
Relationships between endpoints
↥Index endpoint: R18_ANOREXIA – Anorexia
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data